Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GILD
GILD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GILD News
U.S. Launches Investigation into Germany's Pharma Policies
15h ago
CNBC
Gilead's HIV Prevention Drug Filing Accepted by FDA
2d ago
NASDAQ.COM
Rackspace Partners with AMD for 30MW Computing Capacity Deployment
3d ago
CNBC
Gilead's Yeztugo Receives FDA Acceptance for HIV Prevention
3d ago
NASDAQ.COM
Gilead's Application for Weekly HIV Prevention Pill Accepted by FDA
4d ago
seekingalpha
Future Outlook for Obesity Drugs Market
6d ago
CNBC
Gilead Sciences Accelerates HIV Drug Access in South Africa
6d ago
Yahoo Finance
Gilead Donates Antiviral Therapy to Uganda for Ebola Response
Jun 12 2026
Newsfilter
US Stocks Rebound as AI Trade Continues to Gain Momentum
Jun 09 2026
NASDAQ.COM
Merck and Gilead's Combination Pill Trials Achieve Primary Endpoint
Jun 08 2026
seekingalpha
Merck and Gilead Discontinue Joint Study of Trodelvy and Keytruda
Jun 08 2026
Newsfilter
Merck and Gilead Collaborate on Novel HIV Treatment
Jun 08 2026
Newsfilter
Gilead Acquires Ouro Medicines to Enhance Immunology Pipeline
Jun 07 2026
Yahoo Finance
AstraZeneca CEO Discusses AI's Role in Drug Development
Jun 05 2026
CNBC
Gilead Acquires Ouro Medicines for $1.675 Billion
Jun 05 2026
NASDAQ.COM
Gilead Accelerates Access to HIV Prevention Drug in South Africa
Jun 05 2026
Newsfilter
Show More News
